Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Jun. 30, 2019
CURRENT ASSETS
Cash	$ 15,395	$ 27,453
Prepaid expenses and other assets	16,583	9,470
Tax refunds receivable	5,517	6,852
Accounts receivable, net	14,508	29,525
Note receivable, related party	985	5,671
Total Current Assets	52,988	78,971
Operating lease right-of-use asset	3,002	0
TOTAL ASSETS	55,990	78,971
CURRENT LIABILITIES
Accounts payable and accrued expenses	125,435	164,145
Accrued interest - related party	34,783	28,458
Notes payable - related party	538,358	478,357
Operating lease liability	3,002	0
Total Current Liabilities	701,578	670,960
STOCKHOLDERS' DEFICIT
Preferred stock, no par value; 10,000,000 shares authorized, -0- shares issued and outstanding	0	0
Common stock, no par value; 250,000,000 shares authorized 201,533,598 and 199,295,503 shares issued and 201,479,842 and 199,241,747 shares outstanding respectively	33,012,261	32,967,499
Additional paid-in capital	4,513,328	4,513,328
Treasury stock, at cost	(19,387)	(19,387)
Accumulated other comprehensive income	92,212	91,447
Accumulated deficit	(37,600,416)	(37,503,684)
Total Sangui Biotech International, Inc's stockholders' equity (defict)	(2,002)	49,203
Non-controlling interest	(643,586)	(641,192)
Total Stockholders' Deficit	(645,588)	(591,989)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 55,990	$ 78,971